October 30, 2024
Teladoc Health Reports Third Quarter 2024 Results
PURCHASE, NY, Oct. 30, 2024 (GLOBE NEWSWIRE) - Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the three months ended September 30, 2024 (“Third Quarter 2024”). Unless otherwise noted, percentage and other changes are relative to the three months ended September 30, 2023 (“Third Quarter 2023”). Third Quarter 2024 Highlights Third Quarter 2024 revenue of $640.5 million, do wn 3% year-over-year Third Quarter 2024 net loss of $33.3 million, or $0.19 per share Third Quarter 2024 adjusted EBITDA of $83.3 million , down 6% year-over-year Integrated Care segment revenue of $383.7 million , up 2% year-over-year, and adjusted EBITDA margin improved to 17.7% BetterHelp segment revenue of $256.8 million , down 10% year-over-year, and adjusted EBITDA margin of 5.9% “I am pleased with our third quarter results, which demonstrate our commitment to consistent execution, and I remain excited about our...
Read More
October 16, 2024
Teladoc Health to Announce Third Quarter 2024 Financial Results
PURCHASE, NY, Oct. 16, 2024 (GLOBE NEWSWIRE) - Teladoc Health Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced that it will release third quarter 2024 results on Wednesday, October 30, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day.
Conference Call Details
The conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 781291. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/events/global-numbers?confId=72270 . A live audio webcast will also be available online at https://ir.teladoc.com/news-and-events/events-and-presentations/ . A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days. About Teladoc...
Read More